Binder profile
ZINC168710738
Virtual-screening candidate from ZINC.
Bound to: PA3700 — lysine--tRNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC168710738- UniProt (similar protein)
Q9RHV9- Tanimoto
- 0.809
- Target protein
- PA3700
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 474.5
- LogP ≤ 5 -4.00
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 14
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 260.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
NC(=O)CC[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@H]1ONC(=O)CC[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@H]1O
InChI=1S/C15H22N8O8S/c16-6(1-2-8(17)24)14(27)22-32(28,29)30-3-7-10(25)11(26)15(31-7)23-5-21-9-12(18)19-4-20-13(9)23/h4-7,10-11,15,25-26H,1-3,16H2,(H2,17,24)(H,22,27)(H2,18,19,20)/t6-,7+,10-,11+,15+/m0/s1InChI=1S/C15H22N8O8S/c16-6(1-2-8(17)24)14(27)22-32(28,29)30-3-7-10(25)11(26)15(31-7)23-5-21-9-12(18)19-4-20-13(9)23/h4-7,10-11,15,25-26H,1-3,16H2,(H2,17,24)(H,22,27)(H2,18,19,20)/t6-,7+,10-,11+,15+/m0/s1
KXWKSWRGZLZHEF-XJNPZIKMSA-NKXWKSWRGZLZHEF-XJNPZIKMSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- KAA
- Homolog
- Q9RHV9
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC168710738 →
- ZINC ZINC20 ZINC168710738 →
- UniProt UniProt Q9RHV9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC168710738”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3700.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).